IVIG Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

IVIG Market
IVIG Market: By Application (Hypogammaglobulinemia, CIDP, Immunodeficiency diseases, Congenital AIDS, Chronic Lymphocytic Leukemia, Myasthenia Gravis, Multifocal Motor Neuropathy, ITP, Kawasaki Disease, Guillain-Barre Syndrome), By Route of Administration (Intravenous, Subcutaneous), By Geography - Forecast(2018 - 2023)
Report Code : HCR 0233
Updated Date: 15 May, 2018  

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. Intravenous Immunoglobulin – Market Overview
2. Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Intravenous Immunoglobulin – Market Forces
   4.1. Drivers
      4.1.1. Rising reported of immunodeficiency diseases
      4.1.2. Increasing penetration of immunoglobulin replacement therapy
   4.2. Restraints
      4.2.1. Cost of IVIG therapy
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Intravenous Immunoglobulin – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Intravenous Immunoglobulin  Market, By Application
   6.1. Hypogammaglobulinemia
   6.2. CIDP
   6.3. Immunodeficiency diseases
   6.4. Congenital AIDS
   6.5. Chronic Lymphocytic Leukemia
   6.6. Myasthenia Gravis
   6.7. Multifocal Motor Neuropathy
   6.8. ITP
   6.9. Kawasaki Disease
   6.10. Guillain-Barre Syndrome
   6.11. Others
7. Intravenous Immunoglobulin  Market, By Route of Administration
   7.1. Intravenous
   7.2. Subcutaneous
8. Intravenous Immunoglobulin  Market, By Clinical Trial Phase
   8.1. IgG
   8.2. IgA
   8.3. IgM
   8.4. IgE
   8.5. IgD
9. Intravenous Immunoglobulin  Market, By Geography
   9.1. Europe
      9.1.1. Germany
      9.1.2. France
      9.1.3. Italy
      9.1.4. Spain
      9.1.5. Russia
      9.1.6. U.K.
      9.1.7. Rest of Europe
   9.2. Asia Pacific
      9.2.1. China
      9.2.2. India
      9.2.3. Japan
      9.2.4. South Korea
      9.2.5. Rest of Asia-Pacific
   9.3. North America
      9.3.1. U.S.
      9.3.2. Canada
      9.3.3. Mexico
   9.4. Rest of the World (RoW)
      9.4.1. Brazil
      9.4.2. Rest of RoW
10. Intravenous Immunoglobulin – Market Entropy
   10.1. Expansion
   10.2. Technological Developments
   10.3. Merger & Acquisitions, and Joint Ventures
   10.4. Supply- Contract
11. Company Profiles (By- Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)
   11.1. Baxter International Inc.
   11.2. China Biologics Products, Inc.
   11.3. Biotest AG
   11.4. Octapharma AG
   11.5. LFB Biotechnologies
   11.6. Grifols SA
   11.7. Kedrion Biopharma
   11.8. Changchun Bio
   11.9. CSL Behring
   11.10. Hualan Biological Engineering Inc.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix

   12.1. Abbreviations
   12.2. Sources
   12.3. Research Methodology
   12.4. Expert Insights
Immunoglobulin refers to the breakdown of blood plasma that contains antibody and Intravenous immunoglobulin (IVIG) can be defined as a blood product administered intravenously. This therapy applicable for individuals who cannot produce adequate amount of antibodies. Intravenous immunoglobulin therapy helps patients with common variable immunodeficiency, Wiskott Aldrich Syndrome, X-linked agammaglobulinemia and other forms of hypogammaglobulinemia.

This report identifies the intravenous immunoglobulin market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to intravenous immunoglobulin market.

IVIG Market

Globally North America dominated the market for intravenous immunoglobulin in 2015 with highest market share due to higher awareness about intravenous immunoglobulin coupled with developed medical and healthcare establishment in the region. North America was followed by Europe and Asia-Pacific as the second and third largest regional market respectively, for intravenous immunoglobulin. However, Asia-Pacific is expected to be fastest growing regional segment during the period of study due to fast growing healthcare setup in the region especially in India and China along with growing intravenous immunoglobulin therapy in this region.
  • This report on global intravenous immunoglobulin covers different applications of intravenous immunoglobulin therapy, and also classifies the global intravenous immunoglobulin market based on the basis of route of administration and clinical trial phase and market size in various geographical regions.
  • On the basis of delivery method of the intravenous immunoglobulin, this report is segmented into two major segments as follows: Intravenous, Subcutaneous
  • This reports is also classified on the basis of applications of intravenous immunoglobulin therapy, based on this global intravenous immunoglobulin therapy market is classified into ten major segments as follows: Hypogammaglobulinemia, CIDP, Immunodeficiency diseases, Congenital AIDS, Chronic Lymphocytic Leukemia, Myasthenia Gravis, Multifocal Motor Neuropathy, ITP, Kawasaki Disease, Guillain-Barre Syndrome and others
  • This report also covers intravenous immunoglobulin therapy market on the basis of clinical trial outlooks, major segments covered in this report are as follows:  IgG, IgA, IgM, IgE and IgD
  • This is report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for intravenous immunoglobulin  in each of the region.

This report identifies all the major companies operating in the global intravenous immunoglobulin market. Some of the major companies’ profiles in detail are as follows:
  • Baxter International Inc.
  • China Biologics Products, Inc.
  • Biotest AG
  • Octapharma AG
  • LFB Biotechnologies
List of Tables
Table 1 IVIG Market Overview 2017-2023
Table 2 IVIG Market Leader Analysis 2017-2018 (US$)
Table 3 IVIG MarketProduct Analysis 2017-2018 (US$)
Table 4 IVIG MarketEnd User Analysis 2017-2018 (US$)
Table 5 IVIG MarketPatent Analysis 2013-2018* (US$)
Table 6 IVIG MarketFinancial Analysis 2017-2018 (US$)
Table 7 IVIG Market Driver Analysis 2017-2018 (US$)
Table 8 IVIG MarketChallenges Analysis 2017-2018 (US$)
Table 9 IVIG MarketConstraint Analysis 2017-2018 (US$)
Table 10 IVIG Market Supplier Bargaining Power Analysis 2017-2018 (US$)
Table 11 IVIG Market Buyer Bargaining Power Analysis 2017-2018 (US$)
Table 12 IVIG Market Threat of Substitutes Analysis 2017-2018 (US$)
Table 13 IVIG Market Threat of New Entrants Analysis 2017-2018 (US$)
Table 14 IVIG Market Degree of Competition Analysis 2017-2018 (US$)
Table 15 IVIG MarketValue Chain Analysis 2017-2018 (US$)
Table 16 IVIG MarketPricing Analysis 2018-2023 (US$)
Table 17 IVIG MarketOpportunities Analysis 2018-2023 (US$)
Table 18 IVIG MarketProduct Life Cycle Analysis 2018-2023 (US$)
Table 19 IVIG MarketSupplier Analysis 2017-2018 (US$)
Table 20 IVIG MarketDistributor Analysis 2017-2018 (US$)
Table 21 IVIG Market Trend Analysis 2017-2018 (US$)
Table 22 IVIG Market Size 2017 (US$)
Table 23 IVIG Market Forecast Analysis 2018-2023 (US$)
Table 24 IVIG Market Sales Forecast Analysis 2018-2023 (Units)
Table 25 IVIG Market, Revenue & Volume,By Route of Administration, 2018-2023 ($)
Table 26 IVIG MarketBy Route of Administration, Revenue & Volume,By Intravenous, 2018-2023 ($)
Table 27 IVIG MarketBy Route of Administration, Revenue & Volume,By Subcutaneous, 2018-2023 ($)
Table 28 IVIG Market, Revenue & Volume,By Application, 2018-2023 ($)
Table 29 IVIG MarketBy Application, Revenue & Volume,By Hypogammaglobulinemia, 2018-2023 ($)
Table 30 IVIG MarketBy Application, Revenue & Volume,By CIDP, 2018-2023 ($)
Table 31 IVIG MarketBy Application, Revenue & Volume,By Immunodeficiency diseases, 2018-2023 ($)
Table 32 IVIG MarketBy Application, Revenue & Volume,By Congenital AIDS, 2018-2023 ($)
Table 33 IVIG MarketBy Application, Revenue & Volume,By Chronic Lymphocytic Leukemia, 2018-2023 ($)
Table 34 IVIG Market, Revenue & Volume,By Clinical Trial Phase, 2018-2023 ($)
Table 35 IVIG MarketBy Clinical Trial Phase, Revenue & Volume,By IgG, 2018-2023 ($)
Table 36 IVIG MarketBy Clinical Trial Phase, Revenue & Volume,By IgA, 2018-2023 ($)
Table 37 IVIG MarketBy Clinical Trial Phase, Revenue & Volume,By IgM, 2018-2023 ($)
Table 38 IVIG MarketBy Clinical Trial Phase, Revenue & Volume,By IgE, 2018-2023 ($)
Table 39 IVIG MarketBy Clinical Trial Phase, Revenue & Volume,By IgD, 2018-2023 ($)
Table 40 North America IVIG Market, Revenue & Volume,By Route of Administration, 2018-2023 ($)
Table 41 North America IVIG Market, Revenue & Volume,By Application, 2018-2023 ($)
Table 42 North America IVIG Market, Revenue & Volume,By Clinical Trial Phase, 2018-2023 ($)
Table 43 South america IVIG Market, Revenue & Volume,By Route of Administration, 2018-2023 ($)
Table 44 South america IVIG Market, Revenue & Volume,By Application, 2018-2023 ($)
Table 45 South america IVIG Market, Revenue & Volume,By Clinical Trial Phase, 2018-2023 ($)
Table 46 Europe IVIG Market, Revenue & Volume,By Route of Administration, 2018-2023 ($)
Table 47 Europe IVIG Market, Revenue & Volume,By Application, 2018-2023 ($)
Table 48 Europe IVIG Market, Revenue & Volume,By Clinical Trial Phase, 2018-2023 ($)
Table 49 APAC IVIG Market, Revenue & Volume,By Route of Administration, 2018-2023 ($)
Table 50 APAC IVIG Market, Revenue & Volume,By Application, 2018-2023 ($)
Table 51 APAC IVIG Market, Revenue & Volume,By Clinical Trial Phase, 2018-2023 ($)
Table 52 Middle East & Africa IVIG Market, Revenue & Volume,By Route of Administration, 2018-2023 ($)
Table 53 Middle East & Africa IVIG Market, Revenue & Volume,By Application, 2018-2023 ($)
Table 54 Middle East & Africa IVIG Market, Revenue & Volume,By Clinical Trial Phase, 2018-2023 ($)
Table 55 Russia IVIG Market, Revenue & Volume,By Route of Administration, 2018-2023 ($)
Table 56 Russia IVIG Market, Revenue & Volume,By Application, 2018-2023 ($)
Table 57 Russia IVIG Market, Revenue & Volume,By Clinical Trial Phase, 2018-2023 ($)
Table 58 Israel IVIG Market, Revenue & Volume,By Route of Administration, 2018-2023 ($)
Table 59 Israel IVIG Market, Revenue & Volume,By Application, 2018-2023 ($)
Table 60 Israel IVIG Market, Revenue & Volume,By Clinical Trial Phase, 2018-2023 ($)
Table 61 Top Companies 2017 (US$)IVIG Market, Revenue & Volume,,
Table 62 Product Launch 2017-2018IVIG Market, Revenue & Volume,,
Table 63 Mergers & Acquistions 2017-2018IVIG Market, Revenue & Volume,,
List of Figures
Figure 1 Overview of IVIG Market 2017-2023
Figure 2 Market Share Analysis for IVIG Market 2017 (US$)
Figure 3 Product Comparison in IVIG Market 2017-2018 (US$)
Figure 4 End User Profile for IVIG Market 2017-2018 (US$)
Figure 5 Patent Application and Grant in IVIG Market 2013-2018* (US$)
Figure 6 Top 5 Companies Financial Analysis in IVIG Market 2017-2018 (US$)
Figure 7 Market Entry Strategy in IVIG Market 2017-2018
Figure 8 Ecosystem Analysis in IVIG Market2017
Figure 9 Average Selling Price in IVIG Market 2017-2023
Figure 10 Top Opportunites in IVIG Market 2017-2018
Figure 11 Market Life Cycle Analysis in IVIG MarketMarket Life Cycle Analysis in 3D Printing
Figure 12 GlobalBy Route of AdministrationIVIG Market Revenue, 2018-2023 ($)
Figure 13 GlobalBy ApplicationIVIG Market Revenue, 2018-2023 ($)
Figure 14 GlobalBy Clinical Trial PhaseIVIG Market Revenue, 2018-2023 ($)
Figure 15 Global IVIG Market - By Geography
Figure 16 Global IVIG Market Value & Volume, By Geography, 2018-2023 ($) 
Figure 17 Global IVIG Market CAGR, By Geography, 2018-2023 (%)
Figure 18 North America IVIG Market Value & Volume, 2018-2023 ($)
Figure 19 US IVIG Market Value & Volume, 2018-2023 ($)
Figure 20 US GDP and Population, 2017-2018 ($)
Figure 21 US GDP – Composition of 2017, By Sector of Origin
Figure 22 US Export and Import Value & Volume, 2017-2018 ($)
Figure 23 Canada IVIG Market Value & Volume, 2018-2023 ($)
Figure 24 Canada GDP and Population, 2017-2018 ($)
Figure 25 Canada GDP – Composition of 2017, By Sector of Origin
Figure 26 Canada Export and Import Value & Volume, 2017-2018 ($)
Figure 27 Mexico IVIG Market Value & Volume, 2018-2023 ($)
Figure 28 Mexico GDP and Population, 2017-2018 ($)
Figure 29 Mexico GDP – Composition of 2017, By Sector of Origin
Figure 30 Mexico Export and Import Value & Volume, 2017-2018 ($)
Figure 31 South America IVIG MarketSouth America 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 32 Brazil IVIG Market Value & Volume, 2018-2023 ($)
Figure 33 Brazil GDP and Population, 2017-2018 ($)
Figure 34 Brazil GDP – Composition of 2017, By Sector of Origin
Figure 35 Brazil Export and Import Value & Volume, 2017-2018 ($)
Figure 36 Venezuela IVIG Market Value & Volume, 2018-2023 ($)
Figure 37 Venezuela GDP and Population, 2017-2018 ($)
Figure 38 Venezuela GDP – Composition of 2017, By Sector of Origin
Figure 39 Venezuela Export and Import Value & Volume, 2017-2018 ($)
Figure 40 Argentina IVIG Market Value & Volume, 2018-2023 ($)
Figure 41 Argentina GDP and Population, 2017-2018 ($)
Figure 42 Argentina GDP – Composition of 2017, By Sector of Origin
Figure 43 Argentina Export and Import Value & Volume, 2017-2018 ($)
Figure 44 Ecuador IVIG Market Value & Volume, 2018-2023 ($)
Figure 45 Ecuador GDP and Population, 2017-2018 ($)
Figure 46 Ecuador GDP – Composition of 2017, By Sector of Origin
Figure 47 Ecuador Export and Import Value & Volume, 2017-2018 ($)
Figure 48 Peru IVIG Market Value & Volume, 2018-2023 ($)
Figure 49 Peru GDP and Population, 2017-2018 ($)
Figure 50 Peru GDP – Composition of 2017, By Sector of Origin
Figure 51 Peru Export and Import Value & Volume, 2017-2018 ($)
Figure 52 Colombia IVIG Market Value & Volume, 2018-2023 ($)
Figure 53 Colombia GDP and Population, 2017-2018 ($)
Figure 54 Colombia GDP – Composition of 2017, By Sector of Origin
Figure 55 Colombia Export and Import Value & Volume, 2017-2018 ($)
Figure 56 Costa Rica IVIG MarketCosta Rica 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 57 Costa Rica GDP and Population, 2017-2018 ($)
Figure 58 Costa Rica GDP – Composition of 2017, By Sector of Origin
Figure 59 Costa Rica Export and Import Value & Volume, 2017-2018 ($)
Figure 60 Europe IVIG Market Value & Volume, 2018-2023 ($)
Figure 61 U.K IVIG Market Value & Volume, 2018-2023 ($)
Figure 62 U.K GDP and Population, 2017-2018 ($)
Figure 63 U.K GDP – Composition of 2017, By Sector of Origin
Figure 64 U.K Export and Import Value & Volume, 2017-2018 ($)
Figure 65 Germany IVIG Market Value & Volume, 2018-2023 ($)
Figure 66 Germany GDP and Population, 2017-2018 ($)
Figure 67 Germany GDP – Composition of 2017, By Sector of Origin
Figure 68 Germany Export and Import Value & Volume, 2017-2018 ($)
Figure 69 Italy IVIG Market Value & Volume, 2018-2023 ($)
Figure 70 Italy GDP and Population, 2017-2018 ($)
Figure 71 Italy GDP – Composition of 2017, By Sector of Origin
Figure 72 Italy Export and Import Value & Volume, 2017-2018 ($)
Figure 73 France IVIG Market Value & Volume, 2018-2023 ($)
Figure 74 France GDP and Population, 2017-2018 ($)
Figure 75 France GDP – Composition of 2017, By Sector of Origin
Figure 76 France Export and Import Value & Volume, 2017-2018 ($)
Figure 77 Netherlands IVIG Market Value & Volume, 2018-2023 ($)
Figure 78 Netherlands GDP and Population, 2017-2018 ($)
Figure 79 Netherlands GDP – Composition of 2017, By Sector of Origin
Figure 80 Netherlands Export and Import Value & Volume, 2017-2018 ($)
Figure 81 Belgium IVIG Market Value & Volume, 2018-2023 ($)
Figure 82 Belgium GDP and Population, 2017-2018 ($)
Figure 83 Belgium GDP – Composition of 2017, By Sector of Origin
Figure 84 Belgium Export and Import Value & Volume, 2017-2018 ($)
Figure 85 Spain IVIG Market Value & Volume, 2018-2023 ($)
Figure 86 Spain GDP and Population, 2017-2018 ($)
Figure 87 Spain GDP – Composition of 2017, By Sector of Origin
Figure 88 Spain Export and Import Value & Volume, 2017-2018 ($)
Figure 89 Denmark IVIG Market Value & Volume, 2018-2023 ($)
Figure 90 Denmark GDP and Population, 2017-2018 ($)
Figure 91 Denmark GDP – Composition of 2017, By Sector of Origin
Figure 92 Denmark Export and Import Value & Volume, 2017-2018 ($)
Figure 93 APAC IVIG Market Value & Volume, 2018-2023 ($)
Figure 94 China IVIG MarketValue & Volume, 2018-2023
Figure 95 China GDP and Population, 2017-2018 ($)
Figure 96 China GDP – Composition of 2017, By Sector of Origin
Figure 97 China Export and Import Value & Volume, 2017-2018 ($)IVIG MarketChina Export and Import Value & Volume, 2017-2018 ($)
Figure 98 Australia IVIG Market Value & Volume, 2018-2023 ($)
Figure 99 Australia GDP and Population, 2017-2018 ($)
Figure 100 Australia GDP – Composition of 2017, By Sector of Origin
Figure 101 Australia Export and Import Value & Volume, 2017-2018 ($)
Figure 102 South Korea IVIG Market Value & Volume, 2018-2023 ($)
Figure 103 South Korea GDP and Population, 2017-2018 ($)
Figure 104 South Korea GDP – Composition of 2017, By Sector of Origin
Figure 105 South Korea Export and Import Value & Volume, 2017-2018 ($)
Figure 106 India IVIG Market Value & Volume, 2018-2023 ($)
Figure 107 India GDP and Population, 2017-2018 ($)
Figure 108 India GDP – Composition of 2017, By Sector of Origin
Figure 109 India Export and Import Value & Volume, 2017-2018 ($)
Figure 110 Taiwan IVIG MarketTaiwan 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 111 Taiwan GDP and Population, 2017-2018 ($)
Figure 112 Taiwan GDP – Composition of 2017, By Sector of Origin
Figure 113 Taiwan Export and Import Value & Volume, 2017-2018 ($)
Figure 114 Malaysia IVIG MarketMalaysia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 115 Malaysia GDP and Population, 2017-2018 ($)
Figure 116 Malaysia GDP – Composition of 2017, By Sector of Origin
Figure 117 Malaysia Export and Import Value & Volume, 2017-2018 ($)
Figure 118 Hong Kong IVIG MarketHong Kong 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 119 Hong Kong GDP and Population, 2017-2018 ($)
Figure 120 Hong Kong GDP – Composition of 2017, By Sector of Origin
Figure 121 Hong Kong Export and Import Value & Volume, 2017-2018 ($)
Figure 122 Middle East & Africa IVIG MarketMiddle East & Africa 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 123 Russia IVIG MarketRussia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 124 Russia GDP and Population, 2017-2018 ($)
Figure 125 Russia GDP – Composition of 2017, By Sector of Origin
Figure 126 Russia Export and Import Value & Volume, 2017-2018 ($)
Figure 127 Israel IVIG Market Value & Volume, 2018-2023 ($)
Figure 128 Israel GDP and Population, 2017-2018 ($)
Figure 129 Israel GDP – Composition of 2017, By Sector of Origin
Figure 130 Israel Export and Import Value & Volume, 2017-2018 ($)
Figure 131 Entropy Share, By Strategies, 2017-2018* (%)IVIG Market
Figure 132 Developments, 2017-2018*IVIG Market
Figure 133 Company 1 IVIG Market Net Revenue, By Years, 2017-2018* ($)
Figure 134 Company 1 IVIG Market Net Revenue Share, By Business segments, 2017 (%)
Figure 135 Company 1 IVIG Market Net Sales Share, By Geography, 2017 (%)
Figure 136 Company 2 IVIG Market Net Revenue, By Years, 2017-2018* ($)
Figure 137 Company 2 IVIG Market Net Revenue Share, By Business segments, 2017 (%)
Figure 138 Company 2 IVIG Market Net Sales Share, By Geography, 2017 (%)
Figure 139 Company 3IVIG Market Net Revenue, By Years, 2017-2018* ($)
Figure 140 Company 3IVIG Market Net Revenue Share, By Business segments, 2017 (%)
Figure 141 Company 3IVIG Market Net Sales Share, By Geography, 2017 (%)
Figure 142 Company 4 IVIG Market Net Revenue, By Years, 2017-2018* ($)
Figure 143 Company 4 IVIG Market Net Revenue Share, By Business segments, 2017 (%)
Figure 144 Company 4 IVIG Market Net Sales Share, By Geography, 2017 (%)
Figure 145 Company 5 IVIG Market Net Revenue, By Years, 2017-2018* ($)
Figure 146 Company 5 IVIG Market Net Revenue Share, By Business segments, 2017 (%)
Figure 147 Company 5 IVIG Market Net Sales Share, By Geography, 2017 (%)
Figure 148 Company 6 IVIG Market Net Revenue, By Years, 2017-2018* ($)
Figure 149 Company 6 IVIG Market Net Revenue Share, By Business segments, 2017 (%)
Figure 150 Company 6 IVIG Market Net Sales Share, By Geography, 2017 (%)
Figure 151 Company 7 IVIG Market Net Revenue, By Years, 2017-2018* ($)
Figure 152 Company 7 IVIG Market Net Revenue Share, By Business segments, 2017 (%)
Figure 153 Company 7 IVIG Market Net Sales Share, By Geography, 2017 (%)
Figure 154 Company 8 IVIG Market Net Revenue, By Years, 2017-2018* ($)
Figure 155 Company 8 IVIG Market Net Revenue Share, By Business segments, 2017 (%)
Figure 156 Company 8 IVIG Market Net Sales Share, By Geography, 2017 (%)
Figure 157 Company 9 IVIG Market Net Revenue, By Years, 2017-2018* ($)
Figure 158 Company 9 IVIG Market Net Revenue Share, By Business segments, 2017 (%)
Figure 159 Company 9 IVIG Market Net Sales Share, By Geography, 2017 (%)
Figure 160 Company 10 IVIG Market Net Revenue, By Years, 2017-2018* ($)
Figure 161 Company 10 IVIG Market Net Revenue Share, By Business segments, 2017 (%)
Figure 162 Company 10 IVIG Market Net Sales Share, By Geography, 2017 (%)
Figure 163 Company 11 IVIG Market Net Revenue, By Years, 2017-2018* ($)
Figure 164 Company 11 IVIG Market Net Revenue Share, By Business segments, 2017 (%)
Figure 165 Company 11 IVIG Market Net Sales Share, By Geography, 2017 (%)
Figure 166 Company 12 IVIG Market Net Revenue, By Years, 2017-2018* ($)
Figure 167 Company 12 IVIG Market Net Revenue Share, By Business segments, 2017 (%)
Figure 168 Company 12 IVIG Market Net Sales Share, By Geography, 2017 (%)
Figure 169 Company 13IVIG Market Net Revenue, By Years, 2017-2018* ($)
Figure 170 Company 13IVIG Market Net Revenue Share, By Business segments, 2017 (%)
Figure 171 Company 13IVIG Market Net Sales Share, By Geography, 2017 (%)
Figure 172 Company 14 IVIG Market Net Revenue, By Years, 2017-2018* ($)
Figure 173 Company 14 IVIG Market Net Revenue Share, By Business segments, 2017 (%)
Figure 174 Company 14 IVIG Market Net Sales Share, By Geography, 2017 (%)
Figure 175 Company 15 IVIG Market Net Revenue, By Years, 2017-2018* ($)
Figure 176 Company 15 IVIG Market Net Revenue Share, By Business segments, 2017 (%)
Figure 177 Company 15 IVIG Market Net Sales Share, By Geography, 2017 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll